ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/31 | 3,955 | 4,015 | 3,905 | 3,955 | -85 | -2.1% | 283,600 |
2021/03/30 | 4,110 | 4,110 | 4,010 | 4,040 | -75 | -1.8% | 229,800 |
2021/03/29 | 4,165 | 4,190 | 4,065 | 4,115 | -70 | -1.7% | 382,000 |
2021/03/26 | 4,145 | 4,200 | 4,040 | 4,185 | +320 | +8.3% | 501,800 |
2021/03/25 | 3,890 | 3,910 | 3,865 | 3,865 | -5 | -0.1% | 133,400 |
2021/03/24 | 3,900 | 3,935 | 3,855 | 3,870 | -65 | -1.7% | 187,100 |
2021/03/23 | 3,995 | 3,995 | 3,935 | 3,935 | -45 | -1.1% | 221,000 |
2021/03/22 | 3,945 | 4,005 | 3,930 | 3,980 | +50 | +1.3% | 221,600 |
2021/03/19 | 3,905 | 3,950 | 3,885 | 3,930 | -15 | -0.4% | 280,000 |
2021/03/18 | 3,935 | 4,000 | 3,910 | 3,945 | +10 | +0.3% | 251,900 |
2021/03/17 | 3,800 | 3,945 | 3,775 | 3,935 | +205 | +5.5% | 328,000 |
2021/03/16 | 3,700 | 3,730 | 3,675 | 3,730 | +10 | +0.3% | 151,700 |
2021/03/15 | 3,715 | 3,735 | 3,680 | 3,720 | +15 | +0.4% | 125,200 |
2021/03/12 | 3,685 | 3,715 | 3,635 | 3,705 | -20 | -0.5% | 193,700 |
2021/03/11 | 3,600 | 3,730 | 3,600 | 3,725 | +125 | +3.5% | 260,500 |
2021/03/10 | 3,530 | 3,625 | 3,525 | 3,600 | +90 | +2.6% | 175,700 |
2021/03/09 | 3,510 | 3,520 | 3,470 | 3,510 | +45 | +1.3% | 117,500 |
2021/03/08 | 3,500 | 3,515 | 3,435 | 3,465 | -15 | -0.4% | 121,400 |
2021/03/05 | 3,430 | 3,480 | 3,410 | 3,480 | +50 | +1.5% | 162,200 |
2021/03/04 | 3,420 | 3,430 | 3,390 | 3,430 | +10 | +0.3% | 96,100 |
2021/03/03 | 3,420 | 3,445 | 3,365 | 3,420 | +5 | +0.1% | 160,000 |
2021/03/02 | 3,405 | 3,415 | 3,365 | 3,415 | +60 | +1.8% | 147,800 |
2021/03/01 | 3,400 | 3,405 | 3,330 | 3,355 | +10 | +0.3% | 94,400 |
2021/02/26 | 3,395 | 3,415 | 3,340 | 3,345 | -50 | -1.5% | 184,300 |
2021/02/25 | 3,435 | 3,440 | 3,375 | 3,395 | +15 | +0.4% | 130,100 |
2021/02/24 | 3,410 | 3,420 | 3,370 | 3,380 | -55 | -1.6% | 119,700 |
2021/02/22 | 3,475 | 3,480 | 3,420 | 3,435 | +30 | +0.9% | 114,200 |
2021/02/19 | 3,470 | 3,490 | 3,390 | 3,405 | -115 | -3.3% | 133,500 |
2021/02/18 | 3,460 | 3,530 | 3,430 | 3,520 | +95 | +2.8% | 165,800 |
2021/02/17 | 3,500 | 3,505 | 3,420 | 3,425 | -100 | -2.8% | 147,300 |
2021/02/16 | 3,440 | 3,540 | 3,420 | 3,525 | +70 | +2% | 170,900 |
2021/02/15 | 3,420 | 3,475 | 3,395 | 3,455 | +55 | +1.6% | 169,800 |
2021/02/12 | 3,425 | 3,430 | 3,385 | 3,400 | +30 | +0.9% | 217,100 |
2021/02/10 | 3,365 | 3,395 | 3,335 | 3,370 | -30 | -0.9% | 215,600 |
2021/02/09 | 3,505 | 3,510 | 3,365 | 3,400 | -115 | -3.3% | 309,900 |
2021/02/08 | 3,560 | 3,560 | 3,345 | 3,515 | -50 | -1.4% | 432,900 |
2021/02/05 | 3,500 | 3,595 | 3,475 | 3,565 | +100 | +2.9% | 272,800 |
2021/02/04 | 3,470 | 3,500 | 3,460 | 3,465 | -5 | -0.1% | 89,500 |
2021/02/03 | 3,420 | 3,485 | 3,420 | 3,470 | +55 | +1.6% | 93,600 |
2021/02/02 | 3,390 | 3,415 | 3,370 | 3,415 | +5 | +0.1% | 115,100 |
2021/02/01 | 3,395 | 3,425 | 3,395 | 3,410 | +5 | +0.1% | 135,100 |
2021/01/29 | 3,420 | 3,490 | 3,400 | 3,405 | -50 | -1.4% | 179,600 |
2021/01/28 | 3,410 | 3,470 | 3,395 | 3,455 | +35 | +1% | 561,800 |
2021/01/27 | 3,405 | 3,465 | 3,405 | 3,420 | +50 | +1.5% | 153,400 |
2021/01/26 | 3,390 | 3,430 | 3,370 | 3,370 | -25 | -0.7% | 144,100 |
2021/01/25 | 3,375 | 3,410 | 3,360 | 3,395 | +50 | +1.5% | 174,000 |
2021/01/22 | 3,390 | 3,390 | 3,330 | 3,345 | -115 | -3.3% | 141,700 |
2021/01/21 | 3,435 | 3,480 | 3,420 | 3,460 | +55 | +1.6% | 157,800 |
2021/01/20 | 3,360 | 3,410 | 3,340 | 3,405 | +60 | +1.8% | 123,600 |
2021/01/19 | 3,355 | 3,360 | 3,315 | 3,345 | -10 | -0.3% | 120,800 |
1001~
1050
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム